Bandingkan Harga & Kinerja Diagnos Laboratorium Utama Tbk. (DGNS) vs Mizuho Leasing Indonesia Tbk. (VRNA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Diagnos Laboratorium Utama Tbk. dan Mizuho Leasing Indonesia Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Mizuho Leasing Indonesia Tbk. diperdagangkan di Rp75 (kapitalisasi pasar 426,55 M, volume 24 jam 1,06 jt). Perbedaan utamanya: Mizuho Leasing Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar, dan Mizuho Leasing Indonesia Tbk. lebih aktif diperdagangkan (1,06 jt vs 963,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | VRNA | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 426,55 M |
Volume | 963,6 rb | 1,06 jt |
Lot | 9,64 rb | 10,63 rb |
Perputaran | 217,67 jt | 82,27 jt |
Harga Rata-rata | 225,89 | 77,4 |
Nilai Transaksi | 217,67 jt | 82,27 jt |
Harga Ekuilibrium Indikatif | 226 | 75 |
Volume Ekuilibrium Indikatif | 1 rb | 90 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →Tentang Mizuho Leasing Indonesia Tbk.
PT Verena Oto Finance (the Company) was established under its original name of PT Maxima Perdana Finance base on notarial deed No.43 of Mrs Sri Nanning, S.H, dated on Jul 21, 1993. The Companys articles of association has been amended several times, most recently by notarial deed No. 32 of Fathiah Helmi, S.H., dated Mar 26, 2007, concerning among others, the change in the Companys name, increase authorized, change in par value, and increase paid-up capital.
Selengkapnya di halaman VRNA →
